
Loading, please wait...

Loading, please wait...

Approach Bias Modification smoking (ApBM) is an emerging digital intervention designed to reprogram the brain's automatic cues toward nicotine. By training users to 'push away' smoking-related imagery while 'pulling' positive alternatives, clinicians hope to reduce the cognitive bias that fuels addiction. A recent qualitative study published in JMIR Human Factors provides deep insights into how patients experience this training over a four-year period.
The study evaluated feedback from 104 participants who used either virtual reality or smartphone-based ApBM. Researchers identified four primary themes: perceived effects, mechanisms of action, training experience, and attribution of success. Notably, participants who understood the rationale behind the 'push-pull' mechanics reported a more positive therapeutic alliance with the digital tool. Furthermore, the active ApBM group demonstrated higher satisfaction scores than those in sham conditions.
Interestingly, the long-term data revealed that many participants remembered the training's intent even four years later. Those in the active training group rated the intervention higher for its applicability to everyday life. Consequently, they were more likely to perceive the training as a legitimate medical tool. Participants also suggested that personalizing the cues could enhance the effectiveness of future digital cessation programs.
From a clinical perspective, these findings emphasize that patient education is vital. Doctors should explain the cognitive science behind Approach Bias Modification smoking sessions to improve patient buy-in. When patients see the training as a way to 'rewire' their impulses, they are more likely to stay engaged. Additionally, this understanding helps them attribute positive outcomes to the intervention itself rather than external luck.
ApBM targets the automatic, non-conscious 'approach' response to smoking cues. By repeatedly practicing avoidance movements, patients can weaken the neurological link between triggers and the urge to smoke.
Participants in the active training group maintained a favorable view of the intervention's applicability. They reported that understanding the training's purpose was essential for its perceived success and long-term impact on their smoking habits.
ApBM is often used as an adjunctive or 'add-on' therapy. While it shows promise in retraining cognitive biases, researchers suggest it works best when combined with standard behavioral counseling and patient education.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References
Machulska A et al. Proximal and Long-Term Participants' Perspectives on Approach Bias Modification for Smoking Cessation: Qualitative Study. JMIR Hum Factors. 2026 Jun 22. doi: 10.2196/93238. PMID: 42329674.
Manning V, et al. Approach Bias and Tobacco Craving as Mechanisms of the Effect of Approach Bias Retraining on Smoking Cessation. Nicotine Tob Res. 2024;26(10):1345-1353.
Wittekind CE, et al. Approach Bias Modification as an Add-On to Smoking Cessation Treatment: A Randomized Controlled Trial. Am J Psychiatry. 2026;183(2):123-131. doi: 10.1176/appi.ajp.20250189.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new qualitative study explores the proximal and long-term (4-year) perspectives of participants using Approach Bias Modification (ApBM) for smoking cessation. Findings reveal that understanding the training's rationale is key to patient satisfaction and perceived effectiveness in quitting.
2 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today